Global Transdermal Skin Patch Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Transdermal Skin Patch Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Transdermal Skin Patch report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Skin Patch market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Relieve Severe Pain and Stop Smoking Cigarettes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Transdermal Skin Patch industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transdermal Skin Patch key manufacturers include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical and Changzhou Siyao, etc. Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson are top 3 players and held % sales share in total in 2022.
Transdermal Skin Patch can be divided into Fentanyl Transdermal Skin Patch, Nicotine Transdermal Skin Patch, Clonidine Transdermal Skin Patch and Buprenorphine Transdermal Skin Patch, etc. Fentanyl Transdermal Skin Patch is the mainstream product in the market, accounting for % sales share globally in 2022.
Transdermal Skin Patch is widely used in various fields, such as Relieve Severe Pain, Stop Smoking Cigarettes, Treat an Overactive Bladder and Others, etc. Relieve Severe Pain provides greatest supports to the Transdermal Skin Patch industry development. In 2022, global % sales of Transdermal Skin Patch went into Relieve Severe Pain filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Skin Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Segment by Type
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Transdermal Skin Patch market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Skin Patch, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Skin Patch industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Skin Patch in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Skin Patch introduction, etc. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Transdermal Skin Patch market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Transdermal Skin Patch industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transdermal Skin Patch key manufacturers include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical and Changzhou Siyao, etc. Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson are top 3 players and held % sales share in total in 2022.
Transdermal Skin Patch can be divided into Fentanyl Transdermal Skin Patch, Nicotine Transdermal Skin Patch, Clonidine Transdermal Skin Patch and Buprenorphine Transdermal Skin Patch, etc. Fentanyl Transdermal Skin Patch is the mainstream product in the market, accounting for % sales share globally in 2022.
Transdermal Skin Patch is widely used in various fields, such as Relieve Severe Pain, Stop Smoking Cigarettes, Treat an Overactive Bladder and Others, etc. Relieve Severe Pain provides greatest supports to the Transdermal Skin Patch industry development. In 2022, global % sales of Transdermal Skin Patch went into Relieve Severe Pain filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Skin Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Segment by Type
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Segment by Application
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Transdermal Skin Patch market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Skin Patch, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Skin Patch industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Skin Patch in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Skin Patch introduction, etc. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Transdermal Skin Patch market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices